Breast cancer care during a pandemic: an opportune time for cryoablation?

Breast Cancer Research and Treatment
Dennis R Holmes

Abstract

Cryoablation is a minimally-invasive percutaneous procedure that is capable of reducing the psychosocial burden of surgical delay while also decreasing the morbidity of breast cancer therapy. The purpose of this editorial is to discuss the potential role of cryoablation for reducing the psychosocial burden of surgical delay during the COVID-19 pandemic by expediting the management of breast cancer while also lessening demand on limited healthcare resources. This editorial critiques current expert opinion recommendations that aim to reduce viral transmission and preserve healthcare resources during the COVID-19 pandemic by advocating delay of elective breast cancer surgery. The editorial summarizes the current state of the evidence that supports the selective use of cryoablation as a definite or stopgap measure in the management of breast cancer during the COVID-19 pandemic or when healthcare resources are limited. As an office-based procedure performed under local anesthesia, cryoablation eliminates the need for operating room personnel and equipment while also reducing the psychosocial impact of delayed breast cancer surgery. By reducing the number of patient and healthcare provider interactions, cryoablation not only decrease...Continue Reading

References

Dec 7, 2013·Expert Review of Medical Devices·Ayaz Aghayev, Servet Tatli
Dec 5, 2017·Current Breast Cancer Reports·Laura M ArthurJ Michael Dixon
Jul 10, 2019·British Journal of Cancer·Maartje van SeijenUNKNOWN PRECISION team
Sep 29, 2019·Annals of Surgical Oncology·William H WardRichard J Bleicher

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
surgical resection
sedation
biopsy
biopsies

Clinical Trials Mentioned

NCT02200705

Related Concepts

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Related Papers

Clinical Privilege White Paper
Clinical Privilege White Paper
Breast Cancer : Targets and Therapy
Claudio PuscedduAlessandro Fancellu
International Journal of Clinical Oncology
Masahiro Takada, Masakazu Toi
© 2022 Meta ULC. All rights reserved